Amanta Healthcare Limited — Q1FY27 earnings call summary

Filed 08 August 2026 · Official transcript

SteriPort platform now 44% of revenue; capacity expanding from 6.6 Cr to 12 Cr bottles/year, commissioning delayed to Q2 FY27
Captive 10.8 MW solar power plant commissioned June 2026, expected to reduce power costs and improve margins
Q1 FY27 revenue INR69 Cr, +5% y-y; EBITDA margin ~22%
SVP facility to start operations by Q4 FY27, focusing on export markets with high-margin products
FY27 SteriPort Line 3 peak revenue expected INR110-120 Cr annualized, with EBITDA margin expansion of 4-5% including solar savings
FY28 peak revenue target INR425 Cr with EBITDA margin 25-26%
Working capital days ~141 due to quarantine requirements; debt expected to reduce by INR30-35 Cr annually
Incremental depreciation from new lines approx INR6 Cr annually